• 中国精品科技期刊
  • 中国高校百佳科技期刊
  • 中国中文核心期刊
  • 中国科学引文数据库核心期刊
Advanced Search
LIU Xuewu, ZHOU Zhiming, JIANG Dejian, LONG Li. Protective effect and mechanism of Jinshuibao tablet on acute kidney injury induced by cisplatin in rats[J]. Journal of China Pharmaceutical University, 2020, 51(1): 76-83. DOI: 10.11665/j.issn.1000-5048.20200112
Citation: LIU Xuewu, ZHOU Zhiming, JIANG Dejian, LONG Li. Protective effect and mechanism of Jinshuibao tablet on acute kidney injury induced by cisplatin in rats[J]. Journal of China Pharmaceutical University, 2020, 51(1): 76-83. DOI: 10.11665/j.issn.1000-5048.20200112
shu

Protective effect and mechanism of Jinshuibao tablet on acute kidney injury induced by cisplatin in rats

More Information
    Graphical Abstract
    • Abstract
  • This study aimed to observe the therapeutic effect and mechanism of Jinshuibao tablet on acute renal injury induced by cisplatin. Acute renal injury models in SD rats were induced separately by single intraperitoneal injection of cisplatin(5 mg/kg)and intravenous injection for 5 consecutive days at a dosage of 2 mg/kg per day. The renal function and renal histopathological changes were observed in rat acute renal injury models after prevention and treatment with Jinshuibao tablet, respectively. The content of tumor necrosis factor(TNF-α)and reactive oxygen species(ROS), the activity of Caspase 3 and the expression of t-p38, p-p38, Bax and Bcl-2 in the kidneys were detected. The results showed that preventive and therapeutic administration of Jinshuibao tablets could both significantly inhibit the increase of the blood urea nitrogen(BUN)and creatinine(CRE), increase the creatinine clearance rate, reduce the contents of TNF-α and ROS, and decrease the activity of Caspase 3 in acute renal injury models induced by cisplatin. The renal histopathological results showed that Jinshuibao tablets could significantly reduce renal histopathology scores, ameliorate renal tubule degeneration and inflammatory infiltration. Western blot results showed that Jinshuibao tablets could significantly decrease the expression of t-p38 and p-p38, while increasing the Bcl-2/Bax ratio in the kidneys. These results suggested that preventive and therapeutic administration of Jinshuibao tablets could both improve renal function and pathological changes of renal tissue, which might be related to the inhibition of TNF-α and the ROS-p38 MAPK-Caspase3 pathway and thus inhibition of apoptosis.
    • FullText(HTML)
    • References (16)
  • [1]
    Chen CJ,Chen CN,Pan QZ,et al.Clinical study on the intervention therapy of Jinshuibao capsule on cisplatins-induced renal toxicity[J].Med Innov China(中国医学创新),2012,9(2):32-33.
    [2]
    Ye XL,Zhen XC,Yang XL,et al.Diclofenac sodium associated acute kidney injury[J].J ADR(药物不良反应杂志),2018,20(2):146-147.
    [3]
    Liu W,Jiang SF,Tu L,et al.Mechanism of JinShuiBao capsule in ameliorating rat pneumoconiosis model[J].J China Pharm Univ(中国药科大学学报),2018,49(4):476-482.
    [4]
    Yan YL,Zhang DM,Wang Y,et al.The comparative study of the effect of intraperitoneal perfusion and intravenous chemotherapy in advanced ovarian cancer[J].J Int Obstet Gynecol(国际妇产科学杂志),2014,41(6):655-657.
    [5]
    Markman M.Intraperitoneal chemotherapy as primary treatment of advanced ovarian cancer:efficacy,toxicity,and future directions[J].Rev Recent Clin Trials,2007,2(3):169-173.
    [6]
    Goren O,Matot I.Update on perioperative acute kidney injury[J].Curr Opin Crit Care,2016,22(4):370-378.
    [7]
    Yan W, Xu Y, Yuan YH, et al. Renoprotective mechanisms of Astragaloside IV in cisplatin-induced acute kidney injury[J].Free Radic Res,2017,51(7/8):669-683.
    [8]
    Mulay SR,Anders HJ.Crystal nephropathies:mechanisms of crystal-induced kidney injury[J].Nat Rev Nephrol,2017,13(4):226-240.
    [9]
    Devarajan P.Acute kidney injury:still misunderstood and misdiagnosed[J].Nat Rev Nephrol,2017,13(3):137-138.
    [10]
    Mansouri A,Ridgway LD,Korapati AL,et al.Sustained activation of JNK/p38 MAPK pathways in response to cisplatin leads to Fas ligand induction and cell death in ovarian carcinoma cells[J].J Biol Chem,2003,278(21):19245-19256.
    [11]
    He B,Tao HY,Liu SQ,et al.Carboxymethylated chitosan protects rat chondrocytes from NO-induced apoptosis via inhibition of the p38/MAPK signaling pathway[J].Mol Med Rep,2016,13(3):2151-2158.
    [12]
    Wang JX,Chen HJ,Cao P,et al.Inflammatory cytokines induce caveolin-1/β-catenin signalling in rat nucleus pulposus cell apoptosis through the p38 MAPK pathway[J].Cell Prolif,2016,49(3):362-372.
    [13]
    Cai QH,Tang Y,Fan SH,et al.In vivo effects of dexmedetomidine on immune function and tumor growth in rats with ovarian cancer through inhibiting the p38MAPK/NF-κB signaling pathway[J].Biomedecine Pharmacother,2017,95:1830-1837.
    [14]
    Goldsmith EJ,Min XS,He HX,et al.Structural studies of MAP kinase cascade components[J].Methods Mol Biol,2010,661:223-237.
    [15]
    Sabio G,Davis RJ.TNF and MAP kinase signalling pathways[J].Semin Immunol,2014,26(3):237-245.
    [16]
    Ashraf M,Ebner M,Wallner C,et al.A p38MAPK/MK2 signaling pathway leading to redox stress,cell death and ischemia/reperfusion injury[J].Cell Commun Signal,2014,12(1):6.
    • Related Articles

  • Related Articles

    [1]CHU Xuxin, BU Fanxue, YIN Tingjie, HUO Meirong. Antitumor strategies based on targeted modulation of tumor-associated macrophages[J]. Journal of China Pharmaceutical University, 2021, 52(3): 261-269. DOI: 10.11665/j.issn.1000-5048.20210301
    [2]FENG Yang, XU Xiao, MO Ran. Advances in lymphatic targeted drug delivery system for treatment of tumor metastasis[J]. Journal of China Pharmaceutical University, 2020, 51(4): 425-432. DOI: 10.11665/j.issn.1000-5048.20200406
    [3]TANG Keqin, LIN Huaqing, LI Shuhong, DONG Lixin, LU Bohong, JIANG Hong. Advances in tumor targeted nanocrystals[J]. Journal of China Pharmaceutical University, 2020, 51(4): 418-424. DOI: 10.11665/j.issn.1000-5048.20200405
    [4]SONG Ke, PAN Hao, HAN Jiayi, CHEN Lijiang. Nano drug delivery system based strategies to target tumor microenvironment[J]. Journal of China Pharmaceutical University, 2018, 49(4): 392-400. DOI: 10.11665/j.issn.1000-5048.20180402
    [5]CAI Han, LIU Yanhong, YIN Tingjie, ZHOU Jianping, HUO Meirong. Advances in the targeted therapy of tumor-associated fibroblasts[J]. Journal of China Pharmaceutical University, 2018, 49(1): 20-25. DOI: 10.11665/j.issn.1000-5048.20180103
    [6]WANG Letian, WANG Jinglin, LIU Hongwu, GE Ying, LI Yuyan, XU Qingxiang. Process in targeted contrast agents for cancer imaging[J]. Journal of China Pharmaceutical University, 2017, 48(6): 635-645. DOI: 10.11665/j.issn.1000-5048.20170602
    [7]SHANG Yunkai, JU Caoyun, XIE Daping, ZHANG Can. Preparation and characterization of tumor targeting doxorubicin liposomesmodified via click chemistry[J]. Journal of China Pharmaceutical University, 2016, 47(6): 708-713. DOI: 10.11665/j.issn.1000-5048.20160613
    [8]XU Yuhong, CAO Jing. Perspectives on targeted nano-drug carriers for tumor treatment[J]. Journal of China Pharmaceutical University, 2013, 44(6): 494-503. DOI: 10.11665/j.issn.1000-5048.20130602
    [9]SHI Yongping, SU Zhigui, XIAO Yanyu, SUN Minjie, PING Qineng, ZONG Li. Preparation and characterization of dual-targeting nanostructure lipid carriers loading mitoxantrone hydrochloride for bone tumor[J]. Journal of China Pharmaceutical University, 2013, 44(4): 321-327. DOI: 10.11665/j.issn.1000-5048.20130407
    [10]LI Sai, XIAO Yan-yu, SU Zhi-gui, SHI Lu, PING Qi-neng, ZHANG Can. Preparation of BSA-coated cationic nanostructure lipid carriers and pharmacokinetics and biodistribution after intravenous injection[J]. Journal of China Pharmaceutical University, 2012, 43(5): 406-411.

Catalog

    Get Citation
    PDF
    XML
    Article views PDF downloads Cited by()
    Turn off MathJax
    Article Contents
    Abstract
    References
    Related Articles

    Copyright © Journal of China Pharmaceutical University苏ICP备12050101号-2

    Address：24 Tongjia Lane, Nanjing City, Jiangsu Province （210009）Tel: 025-83271566E-mail: xuebao@cpu.edu.cn

    Supported by: Beijing Renhe Information Technology Co., Ltd.  Baidu Analytics

    Total visits：315927

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return